Antonello Caruso

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Molecular Docking

Obstructive Sleep Apnea

Cardiac Surgery

Top Venues

ACS pharmacology & translational science

Molecular pharmaceutics

bioRxiv : the preprint server for biology

PLoS computational biology

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Sabine Grüner, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies. ACS pharmacology & translational science 7 (8) (2024)
Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Sabine Grüner, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies. ACS pharmacology & translational science 7 (8) (2024)
Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies. bioRxiv : the preprint server for biology (2024)
Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies. bioRxiv : the preprint server for biology (2024)
Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Sabine Grüner, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies. ACS pharmacology & translational science 7 (8) (2024)
Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies. bioRxiv : the preprint server for biology (2024)
Paulina Jakubiak, Rubén Alvarez-Sánchez, Matthias Fueth, Olaf Broders, Hubert Kettenberger, Kay Stubenrauch, Antonello Caruso
Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats. Molecular pharmaceutics 18 (6) (2021)
Simon Hauri, Paulina Jakubiak, Matthias Fueth, Stefan Dengl, Sara Belli, Rubén Alvarez-Sánchez, Antonello Caruso
Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin. Pharmaceutics 12 (9) (2020)
Antonello Caruso, Jannik Vollmer, Matthias Machacek, Elod Kortvely
Modeling the activation of the alternative complement pathway and its effects on hemolysis in health and disease. PLoS computational biology 16 (10) (2020)
Antonello Caruso, Matthias Füth, Rubén Alvarez-Sánchez, Sara Belli, Cheikh Diack, Katie F Maass, Dietmar Schwab, Hubert Kettenberger, Norman A Mazer
Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction. Molecular pharmaceutics 17 (2) (2020)
Laurence A Hutton-Smith, Eamonn A Gaffney, Helen M Byrne, Antonello Caruso, Philip K Maini, Norman A Mazer
Theoretical Insights into the Retinal Dynamics of Vascular Endothelial Growth Factor in Patients Treated with Ranibizumab, Based on an Ocular Pharmacokinetic/Pharmacodynamic Model. Molecular pharmaceutics 15 (7) (2018)